Roche Resources is intended for UK Healthcare Professionals only. By entering this site you are confirming that you are a UK Healthcare professional.
Skip to main content
Home
Treatment and Screening Checklist
A comprehensive checklist that aims to support HCPs with the administration of OCREVUS SC, this includes sections on:
- Screening checklist for use prior to administration of the injection to the patient, including premedication requirements
- A checklist of required equipment
- Step by step injection preparation
- Checklist for injection site preparation and administration
- Checklist for storage requirements
- Information on injection reactions
Please download the material here
Always consult the SPC for full product information
References:
- OCREVUS IV Summary of Product Characteristics
2. OCREVUS SC Summary of Product Characteristics
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. You can also report via the free Yellow Card app available from the Apple App Store or Google Play Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 367554.
Adverse reactions should be reported by brand name and batch number.
You are about to leave the rocheresources.co.uk environment and will be redirected to another site or resource which may contain information not intended for a UK audience. Roche Products Limited does not endorse or accept liability for sites or resources controlled by third parties.
